Andere talen Jiangsu Nhwa Pharmaceutical Co., LTD

Aandelen

002262

CNE100000CG8

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 01-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
23,76 ^CNY	+0,08%		+2,06%	-12,39%

20/06	Penehyclidinehydrochloride-injectie van Nhwa Pharmaceutical slaagt voor voorgeschreven tests	MT
20/06	Nhwa Pharmaceutical krijgt registratiecertificaat voor pregabaline-capsules	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing	20/06
Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules	20/06
Nhwa Pharma Gets China Nod to Register Epilepsy Drug	24/05
Jiangsu Nhwa Pharmaceutical Co., Ltd Approves Cash Dividend for 2023, Payable on 15 May 2024	25/04
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04
Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets	03/04
Jiangsu Nhwa Pharmaceutical Co., Ltd Proposes Profit Distribution for 2023	01/04
Nhwa Pharmaceutical's 2023 Profit Climbs 15% as Revenue Rises 17%	01/04
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO in China	27/02
Exchange-Traded Funds Higher, Equity Futures Lower Pre-Bell Monday Ahead of Data-Packed Week	26/02
Teva Pharmaceutical Investments Singapore Pte Ltd. and Jiangsu Nhwa Pharmaceutical Co., LTD Forge Strategic Partnership to Promote Patient Access to Austedo® in China	26/02
Nhwa Pharmaceutical Gets Green Light from US FDA After Addressing API Deficiencies	21/12
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	25-10-23
Beijing Yihua M-Health Technology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Jiangsu Nhwa Pharmaceutical Co., LTD	25-10-23
Jiangsu Nhwa Pharmaceutical Co., LTD(XSEC:002262) added to FTSE All-World Index	18-09-23
Jiangsu Nhwa Pharma’s H1 Profit Jumps 21.7% as Revenue Rises 20%	31-07-23
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	30-07-23
Wang Zeyu cancelled the acquisition of 13% stake in Jiangsu Farever Pharma Co., Ltd. from Jiangsu Nhwa Pharmaceutical Co., LTD.	28-07-23
Expected House Vote on Debt Ceiling Deal Weighs on Sentiment, Pushing US Equity Futures Lower	31-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jiangsu Nhwa Pharmaceutical Co., LTD

Aandelen

002262

CNE100000CG8

Andere talen

Filters